iRhythm Technologies, Inc. (IRTC)
USD 105.92
(-2.22%)
USD 105.92
(-2.22%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 492.68 Million USD | 19.9% |
| 2022 | 410.92 Million USD | 27.29% |
| 2021 | 322.82 Million USD | 21.74% |
| 2020 | 265.16 Million USD | 23.59% |
| 2019 | 214.55 Million USD | 45.66% |
| 2018 | 147.29 Million USD | 49.52% |
| 2017 | 98.5 Million USD | 53.75% |
| 2016 | 64.07 Million USD | 77.29% |
| 2015 | 36.14 Million USD | 66.17% |
| 2014 | 21.74 Million USD | 41.52% |
| 2013 | 15.36 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 148.04 Million USD | 12.22% |
| 2024 Q3 | 147.53 Million USD | -0.34% |
| 2024 Q1 | 131.92 Million USD | -0.44% |
| 2023 Q4 | 132.51 Million USD | 6.35% |
| 2023 FY | 492.68 Million USD | 19.9% |
| 2023 Q1 | 111.43 Million USD | -1.05% |
| 2023 Q2 | 124.13 Million USD | 11.39% |
| 2023 Q3 | 124.6 Million USD | 0.38% |
| 2022 Q2 | 102.05 Million USD | 10.47% |
| 2022 Q1 | 92.37 Million USD | 12.93% |
| 2022 Q4 | 112.61 Million USD | 8.42% |
| 2022 FY | 410.92 Million USD | 27.29% |
| 2022 Q3 | 103.87 Million USD | 1.79% |
| 2021 Q1 | 74.31 Million USD | -5.71% |
| 2021 Q4 | 81.8 Million USD | -4.25% |
| 2021 FY | 322.82 Million USD | 21.74% |
| 2021 Q3 | 85.43 Million USD | 5.11% |
| 2021 Q2 | 81.27 Million USD | 9.38% |
| 2020 Q4 | 78.8 Million USD | 9.54% |
| 2020 FY | 265.16 Million USD | 23.59% |
| 2020 Q3 | 71.94 Million USD | 41.4% |
| 2020 Q2 | 50.87 Million USD | -19.92% |
| 2020 Q1 | 63.53 Million USD | 7.5% |
| 2019 Q1 | 47.21 Million USD | 9.41% |
| 2019 FY | 214.55 Million USD | 45.66% |
| 2019 Q4 | 59.1 Million USD | 5.62% |
| 2019 Q3 | 55.95 Million USD | 4.92% |
| 2019 Q2 | 53.33 Million USD | 12.96% |
| 2018 Q4 | 43.15 Million USD | 13.26% |
| 2018 FY | 147.29 Million USD | 49.52% |
| 2018 Q3 | 38.1 Million USD | 7.43% |
| 2018 Q2 | 35.46 Million USD | 16.04% |
| 2018 Q1 | 30.56 Million USD | 8.46% |
| 2017 Q2 | 23.85 Million USD | 11.27% |
| 2017 Q3 | 25.03 Million USD | 4.95% |
| 2017 Q4 | 28.18 Million USD | 12.57% |
| 2017 FY | 98.5 Million USD | 53.75% |
| 2017 Q1 | 21.43 Million USD | 14.61% |
| 2016 Q4 | 18.7 Million USD | 11.47% |
| 2016 FY | 64.07 Million USD | 77.29% |
| 2016 Q3 | 16.78 Million USD | 6.65% |
| 2016 Q1 | 12.85 Million USD | 18.43% |
| 2016 Q2 | 15.73 Million USD | 22.41% |
| 2015 Q2 | 7.97 Million USD | 0.0% |
| 2015 Q4 | 10.85 Million USD | 16.16% |
| 2015 Q3 | 9.34 Million USD | 17.22% |
| 2015 Q1 | 7.97 Million USD | 23.49% |
| 2015 FY | 36.14 Million USD | 66.17% |
| 2014 Q4 | 6.45 Million USD | 0.0% |
| 2014 FY | 21.74 Million USD | 41.52% |
| 2013 FY | 15.36 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -6777.178% |
| Cerus Corporation | 156.36 Million USD | -215.08% |
| OrthoPediatrics Corp. | 148.73 Million USD | -231.254% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -50759.704% |
| Talis Biomedical Corporation | 412 Thousand USD | -119482.767% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -3469.893% |
| Inogen, Inc. | 315.66 Million USD | -56.08% |
| Spectral AI, Inc. | 18.05 Million USD | -2628.628% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -4874.064% |
| CVRx, Inc. | 39.29 Million USD | -1153.801% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -76403.261% |
| Orthofix Medical Inc. | 746.64 Million USD | 34.014% |
| Venus Concept Inc. | 76.35 Million USD | -545.259% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -3985.588% |
| Bioventus Inc. | 512.34 Million USD | 3.838% |
| BrainsWay Ltd. | 31.78 Million USD | -1450.042% |
| Envoy Medical, Inc. | 316 Thousand USD | -155811.709% |
| electroCore, Inc. | 16.03 Million USD | -2973.493% |
| IceCure Medical Ltd | 3.22 Million USD | -15158.006% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -20191.639% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -134881.466% |
| MaxCyte, Inc. | 41.28 Million USD | -1093.279% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -25134.104% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -444766.724% |
| PAVmed Inc | 2.45 Million USD | -19993.026% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -2087.846% |
| RxSight, Inc. | 89.07 Million USD | -453.096% |
| Sight Sciences, Inc. | 81.05 Million USD | -507.828% |
| SI-BONE, Inc. | 138.88 Million USD | -254.738% |
| TELA Bio, Inc. | 58.45 Million USD | -742.867% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -2561.558% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | -163.3% |
| LivaNova PLC | 1.15 Billion USD | 57.29% |
| 908 Devices Inc. | 50.22 Million USD | -880.87% |
| Alphatec Holdings, Inc. | 482.26 Million USD | -2.16% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -639380.037% |
| NeuroPace, Inc. | 65.42 Million USD | -653.093% |
| LENSAR, Inc. | 42.16 Million USD | -1068.487% |
| Apyx Medical Corporation | 52.34 Million USD | -841.147% |
| Cutera, Inc. | 212.36 Million USD | -131.993% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -1376.95% |
| BioSig Technologies, Inc. | 18 Thousand USD | -2737016.667% |
| Anika Therapeutics, Inc. | 166.66 Million USD | -195.617% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -1956.694% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 68.04% |
| Axonics, Inc. | 366.37 Million USD | -34.473% |
| Outset Medical, Inc. | 130.37 Million USD | -277.892% |
| IRIDEX Corporation | 51.86 Million USD | -849.856% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -261.757% |
| IRadimed Corporation | 65.56 Million USD | -651.47% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -41794.643% |
| INVO Bioscience, Inc. | 3.02 Million USD | -16210.835% |
| Telesis Bio, Inc. | 27.5 Million USD | -1690.981% |
| Viemed Healthcare, Inc. | 183 Million USD | -169.213% |
| Varex Imaging Corporation | 811 Million USD | 39.25% |
| Quipt Home Medical Corp. | 221.74 Million USD | -122.187% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -617.41% |
| Dynatronics Corporation | 32.53 Million USD | -1414.359% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -5577.357% |
| Semler Scientific, Inc. | 68.18 Million USD | -622.576% |
| InMode Ltd. | 492.04 Million USD | -0.129% |
| Bruker Corporation | 2.96 Billion USD | 83.381% |
| Cytosorbents Corporation | 36.34 Million USD | -1255.404% |
| DexCom, Inc. | 3.62 Billion USD | 86.399% |
| Align Technology, Inc. | 3.86 Billion USD | 87.244% |
| Viveve Medical, Inc. | 6.42 Million USD | -7566.993% |
| ZimVie Inc. | 457.43 Million USD | -7.706% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | -155.255% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -444766.724% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 34.109% |
| Profound Medical Corp. | 7.33 Million USD | -6620.496% |
| Insulet Corporation | 1.69 Billion USD | 70.969% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -290.775% |
| iCAD, Inc. | 17.31 Million USD | -2744.907% |
| Nuwellis, Inc. | 8.86 Million USD | -5458.224% |
| Biotricity, Inc. | 12.06 Million USD | -3984.116% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -7840.064% |
| PAVmed Inc. | 2.45 Million USD | -19993.026% |
| BIOLASE, Inc. | 49.16 Million USD | -902.117% |
| Beyond Air, Inc. | 1.15 Million USD | -42409.146% |
| FONAR Corporation | 102.88 Million USD | -378.87% |
| AxoGen, Inc. | 159.01 Million USD | -209.839% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | -79.533% |
| Inari Medical, Inc. | 493.63 Million USD | 0.193% |
| UFP Technologies, Inc. | 400.07 Million USD | -23.148% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -2648722.581% |
| Tenon Medical, Inc. | 2.92 Million USD | -16726.537% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -7132.505% |
| AdaptHealth Corp. | 3.2 Billion USD | 84.605% |
| Sintx Technologies, Inc. | 2.62 Million USD | -18654.511% |
| NanoVibronix, Inc. | 2.28 Million USD | -21480.42% |
| Quanterix Corporation | 122.36 Million USD | -302.622% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -1918.771% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | -145.7% |
| TransMedics Group, Inc. | 241.62 Million USD | -103.905% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -3456.236% |
| NeuroMetrix, Inc. | 5.9 Million USD | -8248.509% |
| Hyperfine, Inc. | 11.03 Million USD | -4365.926% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -198.322% |
| Biomerica, Inc. | 5.41 Million USD | -8998.449% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -874.429% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | -178.14% |